Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production
about
Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattiiType I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary Coccidioidomycosis.The Cnes2 locus on mouse chromosome 17 regulates host defense against cryptococcal infection through pleiotropic effects on host immunityCytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapyInterleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitisLipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.Clinical Immunophenotype at Disease Onset in Previously Healthy Patients With Cryptococcal Meningitis.Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection.Cryptococcus: from environmental saprophyte to global pathogen.Memory CD4 T cells in influenza.Local GM-CSF-Dependent Differentiation and Activation of Pulmonary Dendritic Cells and Macrophages Protect against Progressive Cryptococcal Lung Infection in Mice.IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.Role of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection.Innate host defenses against Cryptococcus neoformans.Yin and yang of interleukin-17 in host immunity to infection.IL-17 in the lung: The Good, the Bad, and the Ugly.Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense.Immunization with Antigen-Pulsed Dendritic Cells Against Highly Virulent Cryptococcus gattii Infection: Analysis of Cytokine-Producing T Cells.T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during Cryptococcus neoformans Infection.Treatment with pCramoll Alone and in Combination with Fluconazole Provides Therapeutic Benefits in C. gattii Infected Mice.Early or late IL-10 blockade enhances Th1 and Th17 effector responses and promotes fungal clearance in mice with cryptococcal lung infectionCD4(+) FoxP3(+) regulatory T cells suppress fatal T helper 2 cell immunity during pulmonary fungal infection.CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis.Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects.The F-Box Protein Fbp1 Shapes the Immunogenic Potential of Cryptococcus neoformans.Inhaled Cryptococcus neoformans elicits allergic airway inflammation independent of Nuclear Factor Kappa B signalling in lung epithelial cells.Anti-PD-1 Antibody Treatment Promotes Clearance of Persistent Cryptococcal Lung Infection in Mice.Adaptive Immunity to Cryptococcus neoformans Infections.Contribution of IL-1RI Signaling to Protection against Cryptococcus neoformans 52D in a Mouse Model of Infection.Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome.Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.Interactions of Cryptococcus with Dendritic Cells.
P2860
Q35187555-B79F4542-9C7B-4D9B-8CAF-69821AF60C9EQ35739585-54B5D9E9-84A3-49BE-A92D-40DF98AA2058Q36106888-D9D9178F-5943-4CB7-ABE9-55F446ADF7EAQ36281331-49E868A3-A950-461F-8584-2EB0F915F00DQ36366992-19DD915B-D229-4F0C-BE6B-B3EACCBBE3DEQ36458503-B0ABFFF2-3EB1-4475-B616-A70D32C4C821Q36549032-FF2BFB8A-F6ED-40B4-857F-4F8BBC448560Q36581034-D20A7996-F451-4129-8BB0-36D7A1C5546BQ37120228-A93A2714-E9BE-4FED-B2E4-19EF9FB52AA9Q37250158-46829FF0-B9ED-45CB-B106-3BDD71D6D1D5Q38227519-0C688835-BB04-4800-9E27-A68918752FDEQ38274984-6CDB5224-5F21-43A0-81C1-467BC864690AQ38289321-F68CF9C8-B871-4A2B-B636-3B7560E64DFDQ38644509-6643C7E7-7FAB-4DDC-B6CB-D61B7C8CDCA5Q38752388-FE32B155-10BE-42E2-931B-18CBA1FDAD63Q39438071-6470CA83-3285-46BD-9398-17F1DEE6787EQ40062327-A811F328-AD98-4F66-B327-BAC789126457Q40091655-1126F77B-5079-4005-94BD-7A44DDC96757Q40171425-4C3F8DD0-6CB5-4DE4-80D9-87AA181EC455Q40172231-3C1A046F-A843-41C4-AEB8-2F73B4F93412Q40179467-61F868F3-DFDB-4718-9137-C7C29A61E9CCQ41737626-DE5E80E9-767C-435A-BAD2-3339B4E94307Q41755000-35EB72B4-B4DA-4EC7-B130-313B810CA462Q46784433-CAF8B047-8EE7-44B8-8491-D070D687CAD5Q47164046-719FAF35-07D7-497F-9653-57239B34C0CFQ47215796-F1224B29-64B3-4B4A-920C-49CDE5189BFEQ47621289-F6AE81E0-20A2-4177-993B-933771BB5382Q47643822-F5D955A9-BF79-4440-B8E8-D2BC604A3D0CQ49188733-EBF8EAFA-7CB9-4F5F-A4B3-A35FC20AA5EFQ49447299-C224E856-F8A4-47C4-AFA8-FD010559853FQ49679752-4F897859-D118-438E-A707-BB16F429963DQ50073548-714CDDFC-BE15-4223-9E31-5BAB5C560E59Q52654069-A8E93450-2B80-45EB-BD0C-F802AC82F677
P2860
Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin-17A enhances host ...... nd gamma interferon production
@en
Interleukin-17A enhances host ...... d gamma interferon production.
@nl
type
label
Interleukin-17A enhances host ...... nd gamma interferon production
@en
Interleukin-17A enhances host ...... d gamma interferon production.
@nl
prefLabel
Interleukin-17A enhances host ...... nd gamma interferon production
@en
Interleukin-17A enhances host ...... d gamma interferon production.
@nl
P2093
P2860
P356
P1476
Interleukin-17A enhances host ...... nd gamma interferon production
@en
P2093
Benjamin J Murdock
Gary B Huffnagle
John J Osterholzer
P2860
P304
P356
10.1128/IAI.01477-13
P407
P577
2013-12-09T00:00:00Z